Generic Name and Formulations:
Biperiden HCl 2mg; tabs.
Indications for AKINETON:
Adjunct in the therapy of all forms of parkinsonism (eg, idiopathic, postencephalitic, arteriosclerotic). To control extrapyramidal disorders secondary to neuroleptic drug therapy (eg, phenothiazines).
Parkinson's disease: 2mg three or four times daily. Individualize and titrate upward to max 16mg/24 hours. Extrapyramidal disorders: 2mg one to three times daily.
Narrow angle glaucoma. Bowel obstruction. Megacolon.
Glaucoma. Prostatism. Epilepsy. Arrhythmia. Pregnancy (Cat.C). Nursing mothers.
Avoid concomitant alcohol. Potentiated anticholinergic effects with drugs that have secondary anticholinergic actions (eg, narcotics analgesics, phenothiazines, tricyclic antidepressants, antiarrhythmics, antihistamines).
Anticholinergic effects (eg, dry mouth, blurred vision, drowsiness, euphoria, disorientation, urinary retention, postural hypotension, constipation, agitation, disturbed behavior); rare: generalized choreic movements, reduction in REM sleep.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Light Therapy May Prevent Depression During Hospitalization Post-Transplant in Multiple Myeloma
- Re-treatment With Checkpoint Inhibitors in Some Patients with NSCLC May Be Feasible
- TNFi Not Linked to Increased Risk for Cancer Recurrence in Rheumatoid Arthritis
- IL-23 Drives Castration-Resistant Prostate Cancer
- Immediate Instillation of Mitomycin C Post-TURBT May Benefit All Patients with Bladder Cancer